Danoflox: new antibiotic for veterinary from Arterium Corporation

In January 2015 Arterium Corporation introduced a novel veterinary product Danoflox, solution for injections on the market of Ukraine.

Danoflox can be used in the treatment of cattle stock affected by acute mastitis, as well as in the respiratory and digestive tract diseases caused by pathogens susceptible to danofloxacin. Following subcutaneous the drug product is rapidly absorbed and distributed in body tissues of the animal.

Danoflox is a veterinary product for cattle stock with active ingredient danofloxacin which with its high efficacy is an economic alternative to the previous generation of fluoroquinolones. By its pharmacological characteristics the drug product belongs to fluoroquinolones, antibacterial veterinary medications of systemic use. The drug product is manufactured at Galychpharm, the production centre of Arterium Corporation. 

Registration certificate No. АВ-05545-01-14 dated 28.11.2014.